PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-36.92%
Negative revenue growth while PONY stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-28.71%
Negative gross profit growth while PONY is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
41.46%
EBIT growth of 41.46% while PONY is zero. Bruce Berkowitz would see if small gains can be scaled further.
36.37%
Operating income growth of 36.37% while PONY is zero. Bruce Berkowitz would see if this modest edge can become significant.
33.37%
Net income growth of 33.37% while PONY is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
34.60%
EPS growth at 50-75% of PONY's 48.36%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
34.60%
Diluted EPS growth of 34.60% while PONY is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
-0.00%
Share reduction while PONY is at 93.11%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-35.14%
Negative OCF growth while PONY is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-34.72%
Negative FCF growth while PONY is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-95.52%
Negative 10Y revenue/share CAGR while PONY stands at 113.35%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-87.79%
Negative 5Y CAGR while PONY stands at 113.35%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-53.53%
Negative 3Y CAGR while PONY stands at 113.35%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-152.98%
Negative 10Y OCF/share CAGR while PONY stands at 0.19%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
63.76%
5Y OCF/share CAGR above 1.5x PONY's 0.19%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-0.65%
Negative 3Y OCF/share CAGR while PONY stands at 0.19%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-298.63%
Negative 10Y net income/share CAGR while PONY is at 21.53%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-439.52%
Negative 5Y net income/share CAGR while PONY is 21.53%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-39.06%
Negative 3Y CAGR while PONY is 21.53%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-46.65%
Negative equity/share CAGR over 10 years while PONY stands at 207.30%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-47.97%
Negative 5Y equity/share growth while PONY is at 207.30%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-45.59%
Negative 3Y equity/share growth while PONY is at 207.30%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while PONY stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while PONY stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.45%
Negative asset growth while PONY invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-9.52%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-20.31%
We’re deleveraging while PONY stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-69.33%
Our R&D shrinks while PONY invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-29.69%
We cut SG&A while PONY invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.